MYC and metastatic malignant neoplasm: Therefore, our results suggest that increased sensitivity to TRAIL in metastatic cancer cells may be in part due to increased expression of c-Myc in the cells, which is associated with up-regulation of DR5 cell surface expression and down-regulation of c-FLIP and Mcl-1.